Search for: "Tom Lamb"
Results 481 - 500
of 1,045
Sort by Relevance
|
Sort by Date
22 Oct 2012, 12:40 pm
Combination Pill Of Topamax And Phentremine Was Approved By FDA, But EMA Points To Heart Side Effects, Birth Defects, And Other Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) On October 18, 2012 European drug regulators took a different course than the FDA with regard to a new anti-obesity medication which contains the active ingredient in Topamax, topiramate, and phentermine. [read post]
15 Oct 2012, 1:58 pm
People Who Suffer These Atypical Femoral Fractures Are Well Treated With This Surgical Procedure Using Rod-Like Nail, With Low Rate Of Complications (Posted by Tom Lamb at DrugInjuryWatch.com) According a recent article about a presentation -- Clinical and functional outcomes in patients who sustained bisphosphonate-associated complete femur fractures. [read post]
9 Oct 2012, 2:37 pm
Concomitant Use Of Tekturna With ACE Inhibitors And ARBs Contraindicated In Patients With Diabetes; Plus An FDA Caution Regarding Renal Impairment (Posted by Tom Lamb at DrugInjuryWatch.com) Tekturna (aliskiren) was approved by the FDA for marketing in March 2007 after it was evaluated for safety in 6,460 patients, and only 1250 patients were treated for longer than 1 year. [read post]
3 Oct 2012, 11:00 am
Newly Available Expert Analysis Of Confidential Drug Company Data Reveals That NuvaRing Estrogen Levels In Studies Were A Cause For Concern, And The Method Of Reporting Was Misleading (Posted by Tom Lamb at DrugInjuryWatch.com) In the pending NuvaRing litigation a federal judge recently unsealed some significant documents previously protected under claims of confidentiality. [read post]
26 Sep 2012, 10:20 am
Use Of Pradaxa After ACS Is Associated With Increased Rate Of Major Bleeding, And Concomitant Use Of Pradaxa With Multaq Is Contraindicated (Posted by Tom Lamb at DrugInjuryWatch.com) When Pradaxa (dabigatran) is used to prevent thrombotic events after an acute coronary syndrome (ACS), it is associated with increased rates of major bleeding that offsets any antithrombotic benefit, according to a September 24, 2012 (Online First) Archives of Internal Medicine article, "Use… [read post]
19 Sep 2012, 2:35 pm
These Fractures Have Several Atypical Characteristics: Prodromal Symptoms, Occurrence With Minimal Trauma, Distinctive Radiographic Changes (Posted by Tom Lamb at DrugInjuryWatch.com) Three new medical journal articles about bisphosphonate-related femur fractures came to our attention in early September 2012. [read post]
12 Sep 2012, 1:45 pm
Heart Drug Multaq Can Cause Pulmonary Fibrosis And Pneumonitis; Symptoms Are Inflammation Of The Lungs, Including Scarring And Thickening (Posted by Tom Lamb at DrugInjuryWatch.com) Multaq (dronedarone) is a drug used to treat abnormal heart rhythm (atrial fibrillation or atrial flutter). [read post]
6 Sep 2012, 11:00 am
Brief History Of This ONJ / Jaw Lawsuit: First, Mistrial; Second, Jury Verdict For Plaintiff But Award Reduced By Judge (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-September 2012 there will be another trial in the federal court Fosamax MDL for osteonecrosis of the jaw (ONJ) / jaw injury cases, but this lawsuit is far from being a "new" matter in that drug injury litigation. [read post]
6 Sep 2012, 11:00 am
Brief History Of This ONJ / Jaw Lawsuit: First, Mistrial; Second, Jury Verdict For Plaintiff But Award Reduced By Judge (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: We have been informed that there will not be a third Boles trial after all because just prior to its start Merck and the attorney for Shirley Boles agreed to a stipulation of damages amount that will be reduced to a… [read post]
31 Aug 2012, 2:30 pm
Approved By FDA In 2010, There Has Been No Study Done Yet Regarding Beyaz Safety -- Despite Significant Number Of Beyaz Adverse Event Reports (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Meeting Materials for Pediatric Focused Safety Review: Beyaz (ethinyl estradiol, drospirenone, levomefolate calcium) Pediatric Advisory Committee Meeting September 11, 2012 (PowerPoint PDF) (9/19/12)… [read post]
27 Aug 2012, 2:58 pm
Increasing Safety Concerns About Novartis Drug Gilenya Are Primarily Cardiovascular Side Effects And Unexplained Death (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2012 Health Canada issued the latest drug safety alert concerning Gilenya (fingolimod), which is is a new kind of immunosuppressant drug that has found a role as a treatment for multiple sclerosis (MS) after failing in clinical trials as a drug to prevent rejection of transplanted kidneys. [read post]
20 Aug 2012, 11:15 am
This Pradaxa MDL Case Will Include Gastrointestinal Bleeding And Other Hemorrhages As Well As Heart Attacks Or Myocardial Infarctions (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa is a blood-thinning drug used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. [read post]
15 Aug 2012, 7:19 am
I'll trade a signed original of my rare 2004 minor league card and throw in a case of soon to be discontinued 2013 Tom Ashes if anyone is looking for a trade.By the rankings, Gould and Lamb (#50) is within tweeting distance of venerable insurance expert Pet Insurance (#48) and solidly more ingrained in the fabric of social media than new comer Pet Pro (#72). [read post]
14 Aug 2012, 12:35 pm
August 2012 CMAJ Medical Journal Article Adds To Hepatotoxicity Evidence Against These Two Fluoroquinolone Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) According to a case-control study published by the Canadian Medical Association Journal (CMAJ) on August 13, 2012, "Fluoroquinolone therapy and idiosyncratic acute liver injury: A population-based study"(full text), the use of two common antibiotics, Avelox (moxifloxacin) and Levaquin (levofloxacin), among older… [read post]
7 Aug 2012, 1:05 pm
NuvaRing Contraceptive Vaginal Ring Associated With Blood Clots In Arteries That Might Cause Thrombotic Strokes And Myocardial Infarctions (MI) (Posted by Tom Lamb at DrugInjuryWatch.com) A Danish study published in June 2012 by The New England of Medicine shows that a woman's use of the NuvaRing birth control product can produce arterial clots leading to a blood-clot related stroke or heart attack. [read post]
7 Aug 2012, 1:05 pm
NuvaRing Contraceptive Vaginal Ring Associated With Blood Clots In Arteries That Might Cause Thrombotic Strokes And Myocardial Infarctions (MI) (Posted by Tom Lamb at DrugInjuryWatch.com) A Danish study published in June 2012 by The New England of Medicine shows that a woman's use of the NuvaRing birth control product can produce arterial clots leading to a blood-clot related stroke or heart attack / myocardial infarction (MI). [read post]
31 Jul 2012, 12:03 pm
Almost 2,000 Lawsuits With Blood Clots Such As DVT And PE Settled, With At Least Another 4,000 Such Cases In Settlement Mediation Negotiations (Posted by Tom Lamb at DrugInjuryWatch.com) From Bayer's Stockholders' Newsletter Second Quarter 2012 (PDF format), at page 50, we get the following update on the Gianvi / Ocella / Yasmin / YAZ litigation: As of July 19, 2012, the number of lawsuits pending in the United States and served upon Bayer was about 12,325 involving… [read post]
25 Jul 2012, 1:55 pm
And Another Medical Journal Article Concludes Venous Thromboembolism (VTE) Risk Associated With NuvaRing Is As High As YAZ Or Yasmin And Ortho Evra (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2012 I wrote this article, "Merck Funded Study Says There Is No Blood Clot Risk With NuvaRing, While BMJ Medical Journal Article Reports A 90% Increased Risk", which pointed out some recent conflicting findings as regards serious NuvaRing side effects involving blood clots,… [read post]
25 Jul 2012, 1:55 pm
And Another Medical Journal Article Concludes Venous Thromboembolism (VTE) Risk Associated With NuvaRing Is As High As YAZ Or Yasmin And Ortho Evra (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2012 I wrote this article, "Merck Funded Study Says There Is No Blood Clot Risk With NuvaRing, While BMJ Medical Journal Article Reports A 90% Increased Risk", which pointed out some recent conflicting findings as regards serious NuvaRing side effects involving blood clots,… [read post]
20 Jul 2012, 1:30 pm
Once The FDA Started Paying Attention The Writing On The Wall Became Apparent, Albeit Too Late For Some (Posted by Tom Lamb at DrugInjuryWatch.com) This lengthy and well-presented news report, "Anemia drugs made billions, but at what cost? [read post]
